Experts are previewing significant data and trials related to genitourinary malignancies at the 2026 ASCO GU conference. The conference is expected to feature practice-changing and practice-informing information, with a focus on kidney cancer and other gu malignancies. Highlights from the conference are being compiled and shared, with some outlets identifying key posts and trials to watch.